Serfaty L - Search Results

1

Impact of steatosis on progression of fibrosis in patients with mild hepatitis C.

Fartoux L, Chazouillères O, Wendum D, Poupon R, Serfaty L. Fartoux L, et al. Among authors: serfaty l. Hepatology. 2005 Jan;41(1):82-7. doi: 10.1002/hep.20519. Hepatology. 2005. PMID: 15690484

2

Combination therapy of chronic viral hepatitis B with lamivudine and interferon: better than what?

Andreani T, Serfaty L, Chazouillères O, Poupon R. Andreani T, et al. Among authors: serfaty l. J Hepatol. 2002 Apr;36(4):572-3; author reply 573. doi: 10.1016/s0168-8278(02)00032-6. J Hepatol. 2002. PMID: 11943435 No abstract available.

3

Effect of interferon alpha-ribavirin bitherapy on cytochrome P450 1A2 and 2D6 and N-acetyltransferase-2 activities in patients with chronic active hepatitis C.

Becquemont L, Chazouilleres O, Serfaty L, Poirier JM, Broly F, Jaillon P, Poupon R, Funck-Brentano C. Becquemont L, et al. Among authors: serfaty l. Clin Pharmacol Ther. 2002 Jun;71(6):488-95. doi: 10.1067/mcp.2002.124468. Clin Pharmacol Ther. 2002. PMID: 12087352 Clinical Trial.

4

Effect of the interaction between steatosis and alcohol intake on liver fibrosis progression in chronic hepatitis C.

Serfaty L, Poujol-Robert A, Carbonell N, Chazouillères O, Poupon RE, Poupon R. Serfaty L, et al. Am J Gastroenterol. 2002 Jul;97(7):1807-12. doi: 10.1111/j.1572-0241.2002.05793.x. Am J Gastroenterol. 2002. PMID: 12135040

5

A randomized controlled trial of ursodeoxycholic acid in patients with alcohol-induced cirrhosis and jaundice.

Pelletier G, Roulot D, Davion T, Masliah C, Causse X, Oberti F, Raabe JJ, Van Lemmens C, Labadie H, Serfaty L; URSOMAF Group. Pelletier G, et al. Among authors: serfaty l. Hepatology. 2003 Apr;37(4):887-92. doi: 10.1053/jhep.2003.50118. Hepatology. 2003. PMID: 12668982 Clinical Trial.

6

Ursodeoxycholic acid therapy and the risk of colorectal adenoma in patients with primary biliary cirrhosis: an observational study.

Serfaty L, De Leusse A, Rosmorduc O, Desaint B, Flejou JF, Chazouilleres O, Poupon RE, Poupon R. Serfaty L, et al. Hepatology. 2003 Jul;38(1):203-9. doi: 10.1053/jhep.2003.50311. Hepatology. 2003. PMID: 12830003

7

Early change in bilirubin levels is an important prognostic factor in severe alcoholic hepatitis treated with prednisolone.

Mathurin P, Abdelnour M, Ramond MJ, Carbonell N, Fartoux L, Serfaty L, Valla D, Poupon R, Chaput JC, Naveau S. Mathurin P, et al. Among authors: serfaty l. Hepatology. 2003 Dec;38(6):1363-9. doi: 10.1016/j.hep.2003.09.038. Hepatology. 2003. PMID: 14647046

8

Reversibility of hepatitis C virus-related cirrhosis.

Pol S, Carnot F, Nalpas B, Lagneau JL, Fontaine H, Serpaggi J, Serfaty L, Bedossa P, Bréchot C. Pol S, et al. Among authors: serfaty l. Hum Pathol. 2004 Jan;35(1):107-12. doi: 10.1016/j.humpath.2003.08.012. Hum Pathol. 2004. PMID: 14745732

9

Genetic and acquired thrombotic factors in chronic hepatitis C.

Poujol-Robert A, Rosmorduc O, Serfaty L, Coulet F, Poupon R, Robert A. Poujol-Robert A, et al. Among authors: serfaty l. Am J Gastroenterol. 2004 Mar;99(3):527-31. doi: 10.1111/j.1572-0241.2004.04092.x. Am J Gastroenterol. 2004. PMID: 15056097

10

Acute hepatic cytolysis in an HIV-infected patient taking atazanavir.

Eholié SP, Lacombe K, Serfaty L, Wendum D, Girard PM. Eholié SP, et al. Among authors: serfaty l. AIDS. 2004 Jul 23;18(11):1610-1. doi: 10.1097/01.aids.0000131369.90575.9e. AIDS. 2004. PMID: 15238786 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

244 results

Search Page

Filters